Ex Vivo Lung Perfusion: A Chance for β2-Agonists to Prove Their Clinical Efficacy in Acute Lung Injury? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Annals of Thoracic Surgery Année : 2016

Ex Vivo Lung Perfusion: A Chance for β2-Agonists to Prove Their Clinical Efficacy in Acute Lung Injury?

Dates et versions

hal-02072194 , version 1 (19-03-2019)

Identifiants

Citer

Raphael Briot, Francis Grimbert. Ex Vivo Lung Perfusion: A Chance for β2-Agonists to Prove Their Clinical Efficacy in Acute Lung Injury?. Annals of Thoracic Surgery, 2016, 102 (1), pp.347. ⟨10.1016/j.athoracsur.2016.01.029⟩. ⟨hal-02072194⟩
934 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More